PlainRecalls
No agency classActive

CPSC recall · Reported March 7, 2018

First Aid Research Recalls Maximum Strength Bacitraycin Plus Ointment With Lidocaine Due to Failure to Meet Child Resistant Closure Requirement

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young childr…

Recall #
18118
Affected scope
About 500,000
Verify with CPSC →
View my saved recalls

First Aid Research Corp., of Jupiter, Fla. recalled This recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine. The recal….

First Aid Research Recalls Maximum Strength Bacitraycin Plus Ointment With Lidocaine Due … was recalled by First Aid Research Corp., of Jupiter, Fla. in March 7, 2018. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving o…. Remedy: Consumers should immediately place the recalled ointment out of the reach of children and…. Verify recall #18118 with the CPSC before acting.

The recall

First Aid Research Corp., of Jupiter, Fla. issued this CPSC recall-The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving o….

None
agency class
March 7, 2018
reported

Sourced from official CPSC enforcement records. Verify recall #18118 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This CPSC action (record #18118) was formally reported on March 7, 2018. The CPSC does not publish a hazard classification for its recalls, so this record carries no agency severity grade, with a current status of Active. First Aid Research Corp., of Jupiter, Fla. is listed as the recalling firm. Federal records list the affected scope as About 500,000.

The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or inges… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's importer, for instructions on how to receive a full refund from the pl… - consumers holding this product should act on that instruction rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,772 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 187

Severity

Not classified by agency

Affected scope

About 500,000

Related Recalls

6

6 from same agency

Product description

This recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine. The recalled ointment is in a white, one ounce tube with "Bacitraycin Plus" printed on the front in green. Lidocaine is one of the two active ingredients listed on the back of the tube. The tube measures approximately 5 inches long by 1 inch wide. The lot number is printed on the end of the tube. The following lot numbers are included in the recall: Lot Numbers 16001 through 16002 404001 through 404002 405001 through 405003 406001 through 406004 407001 through 407002 415001 through 415010 416001 through 416003 417001 through 417004

Reason for recall

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.

Remedy, what to do

Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's importer, for instructions on how to receive a full refund from the place of purchase.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Not classified by agency
Status Active
Recall number 18118
Date reported March 7, 2018
Date initiated March 7, 2018
Recalling firm First Aid Research Corp., of Jupiter, Fla.
Affected scope About 500,000
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's …

  • Check the recall number (18118) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
This recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine. The recalled ointment is in a white, one ounce tube with "Bacitraycin Plus" printed on the front in green. Lidocaine is one of the two active ingredients listed on the back of the tube. The tube measures approximately 5 inches long by 1 inch wide. The lot number is printed on the end of the tube. The following lot numbers are included in the recall: Lot Numbers 16001 through 16002 404001 through 404002 405001 through 405003 406001 through 406004 407001 through 407002 415001 through 415010 416001 through 416003 417001 through 417004. Recalled by First Aid Research Corp., of Jupiter, Fla.. Units affected: About 500,000.
Why was this product recalled?
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What should consumers do?
Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's importer, for instructions on how to receive a full refund from the place of purchase.
Which agency issued this recall?
This recall was issued by the CPSC on March 7, 2018. CPSC does not publish a hazard classification for this recall. Recall number: 18118.
How do I check if my product is affected by a recall?
Check the product description and recall number (18118) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nationwide recalls with similar severity or category timing

Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Showing 5 of 4006 other recalls in this category.

Compare this recall with A2batt Recalls EEMB Lithium Coin Battery Chargers Due to Ri… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported March 7, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.